Gluten-free, casein-free diet

Last updated

A gluten-free casein-free diet (GFCF diet), also known as a gluten-free dairy-free diet (GFDF diet), is a diet that does not include gluten (found most often in wheat, barley, and rye), and casein (found most often in milk and dairy products). Despite an absence of scientific evidence, there have been advocates for the use of this diet as a treatment for autism and related conditions. [1] [2]

Contents

Uses

Autism

The majority of the available evidence does not support the use of this diet in the treatment of autism. [3] [4]

Safety

The diet may have a negative effect on bone health, although there is debate over whether this is actually due to the diet or caused by issues associated with autism. [13]

Mechanism

In the 1960s, Curtis Dohan [14] speculated that the low incidence of schizophrenia in certain South Pacific Island societies was a result of a diet low in wheat and milk-based foods. [15] Dohan proposed a genetic defect wherein individuals are incapable of completely metabolizing gluten and casein as a possible cause for schizophrenia. Dohan hypothesized that elevated peptide levels from this incomplete metabolism could be responsible for schizophrenic behaviors. In 1979, Jaak Panksepp proposed a connection between autism and opiates, noting that injections of minute quantities of opiates in young laboratory animals induce symptoms similar to those observed among autistic children. [16]

The possibility of a relationship between autism and the consumption of gluten and casein was first articulated by Kalle Reichelt in 1991. [17] Based on studies showing correlation between autism, schizophrenia, and increased urinary peptide levels, [18] Reichelt hypothesized that some of these peptides may have an opiate effect. This led to the development of the Opioid excess theory, expounded by Paul Shattock and others, [19] which speculates that peptides with opioid activity cross into the bloodstream from the lumen of the intestine, and then into the brain. These peptides were speculated to arise from incomplete digestion of certain foods, in particular gluten from wheat and certain other cereals and from casein from milk and dairy produce. Further work confirmed opioid peptides such as casomorphines [20] (from casein) and gluten exorphines and gliadorphin (from gluten) as possible suspects, due to their chemical similarity to opiates.

Reichelt hypothesized that long term exposure to these opiate peptides may have effects on brain maturation and contribute to social awkwardness and isolation. On this basis, Reichelt and others have proposed a gluten-free casein-free (GFCF) diet for those with autism to minimize the buildup of opiate peptides. [2] Reichelt has also published a number of trials and reviews concluding that this diet is effective. [21] [22]

Practical implementation

The implementation of a GFCF diet involves removing all sources of gluten and casein from a person's diet. Gluten is found in all products containing wheat, rye, and barley. Many gluten-free breads, pastas, and snacks are available commercially. Gluten-free cookbooks have been available for decades. Casein is found in dairy products such as milk, yogurt or cheese, but is also present in smaller amounts in many substitute dairy products such as vegetarian cheese substitutes and whipped cream topping, which use casein to provide texture.

See also

Related Research Articles

<span class="mw-page-title-main">Casein</span> Family of proteins found in milk

Casein is a family of related phosphoproteins that are commonly found in mammalian milk, comprising about 80% of the proteins in cow's milk and between 20% and 60% of the proteins in human milk. Sheep and cow milk have a higher casein content than other types of milk with human milk having a particularly low casein content.

<span class="mw-page-title-main">Gluten-free diet</span> Diet excluding proteins found in wheat, barley, and rye

A gluten-free diet (GFD) is a nutritional plan that strictly excludes gluten, which is a mixture of prolamin proteins found in wheat, as well as barley, rye, and oats. The inclusion of oats in a gluten-free diet remains controversial, and may depend on the oat cultivar and the frequent cross-contamination with other gluten-containing cereals.

<span class="mw-page-title-main">Conditions comorbid to autism spectrum disorders</span> Medical conditions more common in autistic people

Autism spectrum disorders (ASD) are neurodevelopmental disorders that begin in early childhood, persist throughout adulthood, and affect three crucial areas of development: communication, social interaction and restricted patterns of behavior. There are many conditions comorbid to autism spectrum disorders such as attention-deficit hyperactivity disorder and epilepsy.

<span class="mw-page-title-main">Casomorphin</span> Chemical compound

Casomorphin is an opioid peptide derived from the digestion of the milk protein casein.

Ole Ivar Løvaas was a Norwegian-American clinical psychologist and professor at the University of California, Los Angeles. He is most well known for his research on what is now called applied behavior analysis (ABA) to teach autistic children through prompts, modeling, and positive reinforcement. The therapy is also noted for its use of aversives (punishment) to reduce undesired behavior, however these are now used less commonly than in the past.

Son-Rise is a home-based program for children and adults with autism spectrum disorders and other developmental disabilities, which was developed by Barry Neil Kaufman and Samahria Lyte Kaufman for their son Raun, who was diagnosed with autism and is claimed to have fully recovered from his condition. The program is described by Autism Speaks as a "child-centered program that places parents as the key therapists and directors of their program."

Gluten exorphins are a group of opioid peptides formed during the digestion of the gluten protein. These peptides work as external regulators for gastrointestinal movement and hormonal release. The breakdown of gliadin, a polymer of wheat proteins, creates amino acids that stop the gluten epitopes from entering the immune system to activate inflammatory reactions. During this process, gluten does not fully break down, thus increasing the presence of gluten exorphins. Because of this, researchers think this is what might lead to various diseases.

<span class="mw-page-title-main">Gliadorphin</span> Chemical compound

Gliadorphin is an opioid peptide that is formed during digestion of the gliadin component of the gluten protein. It is usually broken down into amino acids by digestion enzymes. It has been hypothesized that children with autism have abnormal leakage from the gut of this compound. This is partly the basis for the gluten-free, casein-free diet. Abnormally high levels of gliadorphin have been found in the urine of autistic children via mass spectrometry testing.

The following outline is provided as an overview of and topical guide to autism:

<span class="mw-page-title-main">Causes of autism</span> Proposed causes of autism

The causes of autism are environmental or genetic factors that predispose an individual to develop autism, also known as autism spectrum disorder (ASD). Many causes of autism have been proposed, but understanding of the theory of causation of autism is incomplete. Attempts have been made to incorporate the known genetic and environmental causes into a comprehensive causative framework. ASD is a neurodevelopmental disorder marked by impairments in communicative ability and social interaction and restricted/repetitive behaviors, interests, or activities not suitable for the individual's developmental stage. The severity of symptoms and functional impairment vary between individuals.

<span class="mw-page-title-main">Autism therapies</span> Therapy aimed at autistic people

Autism therapies include a wide variety of therapies that help people with autism, or their families. Such methods of therapy seek to aid autistic people in dealing with difficulties and increase their functional independence.

The specific carbohydrate diet (SCD) is a restrictive diet originally created to manage celiac disease; it limits the use of complex carbohydrates. Monosaccharides are allowed, and various foods including fish, aged cheese and honey are included. Prohibited foods include cereal grains, potatoes and lactose-containing dairy products. It is a gluten-free diet since no grains are permitted.

Alternative therapies for developmental and learning disabilities include a range of practices used in the treatment of dyslexia, ADHD, autism spectrum disorders, Down syndrome and other developmental and learning disabilities. Treatments include changes in diet, dietary supplements, biofeedback, chelation therapy, homeopathy, massage and yoga. These therapies generally rely on theories that have little scientific basis, lacking well-controlled, large, randomized trials to demonstrate safety and efficacy; small trials that have reported beneficial effects can be generally explained by the ordinary waxing and waning of the underlying conditions.

<span class="mw-page-title-main">Classic autism</span> Neurodevelopmental condition

Classic autism, also known as childhood autism, autistic disorder, (early) infantile autism, infantile psychosis, Kanner's autism,Kanner's syndrome, or (formerly) just autism, is a neurodevelopmental condition first described by Leo Kanner in 1943. It is characterized by atypical and impaired development in social interaction and communication as well as restricted, repetitive behaviors, activities, and interests. These symptoms first appear in early childhood and persist throughout life.

<span class="mw-page-title-main">Autism spectrum</span> Neurodevelopmental disorder

Autism, formally called autism spectrum disorder (ASD) or autism spectrum condition (ASC), is a neurodevelopmental disorder marked by deficits in reciprocal social communication and the presence of restricted and repetitive patterns of behavior. Other common signs include difficulty with social interaction, verbal and nonverbal communication, along with perseverative interests, stereotypic body movements, rigid routines, and hyper- or hyporeactivity to sensory input. Autism is clinically regarded as a spectrum disorder, meaning that it can manifest very differently in each person. For example, some are nonspeaking, while others have proficient spoken language. Because of this, there is wide variation in the support needs of people across the autism spectrum.

Exorphins are exogenous opioid peptides, distinguished from endorphins, or endogenous opioid peptides.

Paul Shattock is a British autism researcher and scientific consultant to the charity Education and Services for People with Autism, of which he is also the founder. He was formerly the director of the Autism Research Unit at the University of Sunderland. He is well known for his disputed research into dietary therapy and autism, having claimed that autistic children may have a "leaky gut" which allows certain peptides to enter the bloodstream, and claimed that they excrete unusually high levels thereof. As a result of this speculation, he has promoted the use of a gluten-free, casein-free diet to ameliorate the symptoms of autism, a theory he developed along with Kalle Reichelt. In addition, he has claimed that a protein found in milk may play a role in the etiology of autism. He is also the former president of the World Autism Organization.

The opioid excess theory is a theory which postulates that autism is the result of a metabolic disorder in which opioid peptides produced through metabolism of gluten and casein pass through an abnormally permeable intestinal membrane and then proceed to exert an effect on neurotransmission through binding with opioid receptors. It is believed by advocates of this hypothesis that autistic children are unusually sensitive to gluten, which results in small bowel inflammation in these children, which in turn allows these opioid peptides to enter the brain.

Timothy M. Buie is a pediatric gastroenterologist at Boston Children’s Hospital. Buie joined Harvard Medical School in 1998 after previously practicing at Pediatric Gastroenterology Associates for eight years. He was also the director of Gastrointestinal and Nutritional Services at MGH's Lurie Center for Autism. He is well known for his research pertaining to the possible connection between autism and gastrointestinal disorders, and has told the Interagency Autism Coordinating Committee that over half of autistic children experience gastrointestinal symptoms, whereas he stated that this was the case for "between 50 and 70%" of children with autism in an interview with ABC News. He has also said that a subset of autistic children may benefit from gluten-free, casein-free diets, and that more research is needed into this area. Buie was honored as "Professional of the Year" by the Autism Society of America in 2009.

References

  1. 1 2 3 Christison GW, Ivany K; Ivany (2006). "Elimination diets in autism spectrum disorders: any wheat amidst the chaff?". J Dev Behav Pediatr. 27 (2 Suppl 2): S162–71. doi:10.1097/00004703-200604002-00015. PMID   16685183.
  2. 1 2 3 4 Millward C, Ferriter M, Calver S, Connell-Jones G (2008). "Gluten- and casein-free diets for autistic spectrum disorder". Cochrane Database Syst Rev (2): CD003498. doi:10.1002/14651858.CD003498.pub3. PMC   4164915 . PMID   18425890.
  3. Salzberg, Steven. "New Autism Study: Gluten-free Diet Does Not Help Autistic Children". Forbes. Retrieved 2019-12-19.
  4. Digon, Snow (2019-11-18). "Autism Treatment: New Study Reveals Gluten-Free Diet Offers No Benefits For Autistic Children". International Business Times. Retrieved 2019-12-19.
  5. Myers SM, Johnson CP, Council on Children with Disabilities (2007). "Management of children with autism spectrum disorders". Pediatrics. 120 (5): 1162–82. doi: 10.1542/peds.2007-2362 . PMID   17967921.
  6. Mulloy, Austin; Lang, Russell; O'Reilly, Mark; Sigafoos, Jeff; Lancioni, Giulio; Rispoli, Mandy (2010). "Gluten-free and casein-free diets in the treatment of autism spectrum disorders: A systematic review" (PDF). Research in Autism Spectrum Disorders. 4 (3): 328–339. doi:10.1016/j.rasd.2009.10.008.
  7. Warren, Z.; Veenstra-VanderWeele, J.; Stone, W.; Bruzek, J.L.; Nahmias, A.S.; Foss-Feig, J.H.; Jerome, R.N.; Krishnaswami, S.; Sathe, N.A.; Glasser, A.M.; Surawicz, T.; McPheeters, M.L. (2011). Therapies for children with autism spectrum disorders (PDF). AHRQ Publication No. 11-EHC029-EF, Comparative Effectiveness Review No. 26. Rockville, MD: Agency for Healthcare Research and Quality. Archived from the original (PDF) on 2011-10-02.
  8. Buie T (May 2013). "The relationship of autism and gluten". Clin Ther. 35 (5): 578–83. doi: 10.1016/j.clinthera.2013.04.011 . PMID   23688532.
  9. Marí-Bauset, S; Zazpe, I; Mari-Sanchis, A; Llopis-González, A; Morales-Suárez-Varela, M (2014-04-30). "Evidence of the Gluten-Free and Casein-Free Diet in Autism Spectrum Disorders: A Systematic Review". Journal of Child Neurology. 29 (12): 1718–27. doi:10.1177/0883073814531330. hdl: 10171/37087 . PMID   24789114. S2CID   19874518.
  10. Lange, KW; Hauser, J; Reissmann, A (November 2015). "Gluten-free and casein-free diets in the therapy of autism". Current Opinion in Clinical Nutrition and Metabolic Care. 18 (6): 572–5. doi:10.1097/MCO.0000000000000228. PMID   26418822. S2CID   271720.
  11. Tsouderos, Trine; Callahan, Patricia (Nov 22, 2009). "Risky alternative therapies for autism have little basis in science". Chicago Tribune. Retrieved 11 August 2023.
  12. Whiteley, Paul; Shattock, Paul; Knivsberg, Ann-Mari; Seim, Anders; Reichelt, Karl L.; Todd, Lynda; Carr, Kevin; Hooper, Malcolm (2013). "Gluten- and casein-free dietary intervention for autism spectrum conditions". Frontiers in Human Neuroscience. 6: 344. doi: 10.3389/fnhum.2012.00344 . PMC   3540005 . PMID   23316152.
  13. Whiteley, P; Shattock, P; Knivsberg, Ann-Mari; Seim, Anders; Reichelt, Karl L.; Todd, Lynda; Carr, Kevin; Hooper, Malcolm (2012). "Gluten- and casein-free dietary intervention for autism spectrum conditions". Front Hum Neurosci. 6: 344. doi: 10.3389/fnhum.2012.00344 . PMC   3540005 . PMID   23316152.
  14. "Curtis Dohan, M.D., A.B., Associate Professor, The University of Tennessee Health Science Center". Archived from the original on 2016-04-18. Retrieved 2012-02-03.
  15. Dohan, F. C. (1966). "Cereals and schizophrenia data and hypothesis". Acta Psychiatrica Scandinavica. 42 (2): 125–132. doi:10.1111/j.1600-0447.1966.tb01920.x. PMID   5335008. S2CID   38353416.
  16. Panksepp, Jaak (1979). "A neurochemical theory of autism". Trends in Neurosciences. 2: 174–177. doi:10.1016/0166-2236(79)90071-7. S2CID   54373822.
  17. Reichelt KL, Knivsberg A-M, Lind G, Nødland M (1991). "Probable etiology and possible treatment of childhood autism". Brain Dysfunction. 4 (6): 308–19.
  18. Reichelt, K. L.; Hole, K; Hamberger, A; Saelid, G; Edminson, P. D.; Braestrup, C. B.; Lingjaerde, O; Ledaal, P; Orbeck, H (1981). "Biologically active peptide-containing fractions in schizophrenia and childhood autism". Advances in Biochemical Psychopharmacology. 28: 627–43. PMID   7010949.
  19. Shattock, P; Whiteley, P (2002). "Biochemical aspects in autism spectrum disorders: Updating the opioid-excess theory and presenting new opportunities for biomedical intervention". Expert Opinion on Therapeutic Targets. 6 (2): 175–83. doi:10.1517/14728222.6.2.175. PMID   12223079. S2CID   40904799.
  20. Sun Z, Cade JR; Cade (1999). "A peptide found in schizophrenia and autism causes behavioral changes in rats". Autism. 3 (1): 85–95. doi:10.1177/1362361399003001007. S2CID   145579872.
  21. Knivsber, A. M.; Reichelt, K. L.; Nødland, M (2001). "Reports on dietary intervention in autistic disorders". Nutritional Neuroscience. 4 (1): 25–37. doi:10.1080/1028415x.2001.11747348. PMID   11842874. S2CID   29053235.
  22. Knivsberg, A.M.; Reichelt, K.L.; Høien, T.; Nødland, M. (2002). "A Randomised, Controlled Study of Dietary Intervention in Autistic Syndromes". Nutritional Neuroscience. 5 (4): 251–61. doi:10.1080/10284150290028945. PMID   12168688. S2CID   24997219.